Source Natural Foods & Herb Supl Share Price
Sector: Biotechnology & Drugs
178.90 +2.35 (1.33%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
175.00
Today’s High
180.00
52 Week Low
80.20
52 Week High
269.75
Key Metrics
- Market Cap (In Cr) 113.01
- Beta 2.6
- Div. Yield (%) 0
- P/B 5.83
- TTM P/E 47.86
- Sector P/E 26.12
- Open Price 180
- Prev Close 176.55
Source Natural Foods & Herb Supl Analysis
Price Analysis
-
1 Week6.18%
-
3 Months35.5%
-
6 Month-28.87%
-
YTD-8.68%
-
1 Year112.23%
Risk Meter
- 79% Low risk
- 79% Moderate risk
- 79% Balanced Risk
- 79% High risk
- 79% Extreme risk
Source Natural Foods & Herb Supl Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 27.3
- Selling/ General/ Admin Expenses Total
- 2.88
- Depreciation/ Amortization
- 1.04
- Other Operating Expenses Total
- 3.19
- Total Operating Expense
- 23.93
- Operating Income
- 3.37
- Net Income Before Taxes
- 3.18
- Net Income
- 1.74
- Diluted Normalized EPS
- 2.74
- Period
- 2024
- Total Assets
- 23.65
- Total Liabilities
- 4.2
- Total Equity
- 19.45
- Tangible Book Valueper Share Common Eq
- 28.17
- Period
- 2024
- Cashfrom Operating Activities
- 2.69
- Cashfrom Investing Activities
- 0.29
- Cashfrom Financing Activities
- -0.04
- Net Changein Cash
- 2.95
- Period
- 2023
- Total Revenue
- 19.79
- Selling/ General/ Admin Expenses Total
- 3.36
- Depreciation/ Amortization
- 0.43
- Other Operating Expenses Total
- 3.18
- Total Operating Expense
- 16.83
- Operating Income
- 2.96
- Net Income Before Taxes
- 2.74
- Net Income
- 2.12
- Diluted Normalized EPS
- 3.3
- Period
- 2023
- Total Assets
- 21.69
- Total Liabilities
- 3.97
- Total Equity
- 17.72
- Tangible Book Valueper Share Common Eq
- 27.52
- Period
- 2023
- Cashfrom Operating Activities
- 2.51
- Cashfrom Investing Activities
- 0.06
- Cashfrom Financing Activities
- -0.53
- Net Changein Cash
- 2.04
- Period
- 2022
- Total Revenue
- 21.53
- Selling/ General/ Admin Expenses Total
- 3.86
- Depreciation/ Amortization
- 0.42
- Other Operating Expenses Total
- 4.47
- Total Operating Expense
- 18.18
- Operating Income
- 3.34
- Net Income Before Taxes
- 3.68
- Net Income
- 2.43
- Diluted Normalized EPS
- 3.78
- Period
- 2022
- Total Assets
- 19.32
- Total Liabilities
- 3.73
- Total Equity
- 15.6
- Tangible Book Valueper Share Common Eq
- 21.69
- Period
- 2022
- Cashfrom Operating Activities
- -0.7
- Cashfrom Investing Activities
- 0.07
- Cashfrom Financing Activities
- -1.2
- Net Changein Cash
- -1.83
- Period
- 2021
- Total Revenue
- 24.88
- Selling/ General/ Admin Expenses Total
- 2.54
- Depreciation/ Amortization
- 0.37
- Other Operating Expenses Total
- 8.25
- Total Operating Expense
- 21.08
- Operating Income
- 3.8
- Net Income Before Taxes
- 4.03
- Net Income
- 3.37
- Diluted Normalized EPS
- 5.26
- Period
- 2021
- Total Assets
- 17.22
- Total Liabilities
- 4.06
- Total Equity
- 13.16
- Tangible Book Valueper Share Common Eq
- 20.45
- Period
- 2021
- Cashfrom Operating Activities
- 4.42
- Cashfrom Investing Activities
- -2.05
- Cashfrom Financing Activities
- 0.32
- Net Changein Cash
- 2.69
- Period
- 2020
- Total Revenue
- 13.59
- Selling/ General/ Admin Expenses Total
- 2.41
- Depreciation/ Amortization
- 0.34
- Other Operating Expenses Total
- 3.02
- Total Operating Expense
- 11.6
- Operating Income
- 1.99
- Net Income Before Taxes
- 1.85
- Net Income
- 1.64
- Diluted Normalized EPS
- 2.55
- Period
- 2020
- Total Assets
- 13.14
- Total Liabilities
- 3.35
- Total Equity
- 9.79
- Tangible Book Valueper Share Common Eq
- 15.21
- Period
- 2020
- Cashfrom Operating Activities
- -0.36
- Cashfrom Investing Activities
- -0.71
- Cashfrom Financing Activities
- 0.32
- Net Changein Cash
- -0.74
- Period
- 2019
- Total Revenue
- 12.81
- Selling/ General/ Admin Expenses Total
- 2.25
- Depreciation/ Amortization
- 0.34
- Other Operating Expenses Total
- 3.06
- Total Operating Expense
- 11.59
- Operating Income
- 1.21
- Net Income Before Taxes
- 1.06
- Net Income
- 1.03
- Diluted Normalized EPS
- 1.59
- Period
- 2019
- Total Assets
- 10.8
- Total Liabilities
- 2.01
- Total Equity
- 8.79
- Tangible Book Valueper Share Common Eq
- 13.66
- Period
- 2019
- Cashfrom Operating Activities
- 2.64
- Cashfrom Investing Activities
- -0.31
- Cashfrom Financing Activities
- -1.6
- Net Changein Cash
- 0.74
- Period
- 2024-12-31
- Total Revenue
- 10.45
- Selling/ General/ Admin Expenses Total
- 0.93
- Depreciation/ Amortization
- 0.25
- Other Operating Expenses Total
- 0.78
- Total Operating Expense
- 9.04
- Operating Income
- 1.4
- Net Income Before Taxes
- 1.22
- Net Income
- 1.02
- Diluted Normalized EPS
- 1.58
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 10.25
- Selling/ General/ Admin Expenses Total
- 0.74
- Depreciation/ Amortization
- 0.26
- Other Operating Expenses Total
- 0.8
- Total Operating Expense
- 9.14
- Operating Income
- 1.12
- Net Income Before Taxes
- 0.94
- Net Income
- 0.84
- Diluted Normalized EPS
- 1.3
- Period
- 2024-09-30
- Total Assets
- 31.29
- Total Liabilities
- 10.58
- Total Equity
- 20.71
- Tangible Book Valueper Share Common Eq
- 30.64
- Period
- 2024-09-30
- Cashfrom Operating Activities
- -2.98
- Cashfrom Investing Activities
- -1.24
- Cashfrom Financing Activities
- 4.64
- Net Changein Cash
- 0.42
- Period
- 2024-06-30
- Total Revenue
- 8.16
- Selling/ General/ Admin Expenses Total
- 0.75
- Depreciation/ Amortization
- 0.26
- Other Operating Expenses Total
- 0.69
- Total Operating Expense
- 7.52
- Operating Income
- 0.63
- Net Income Before Taxes
- 0.57
- Net Income
- 0.42
- Diluted Normalized EPS
- 0.65
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 6.83
- Selling/ General/ Admin Expenses Total
- 0.5
- Depreciation/ Amortization
- 0.26
- Other Operating Expenses Total
- 0.67
- Total Operating Expense
- 5.65
- Operating Income
- 1.17
- Net Income Before Taxes
- 1.13
- Net Income
- 0.32
- Diluted Normalized EPS
- 0.55
- Period
- 2024-03-31
- Total Assets
- 23.65
- Total Liabilities
- 4.2
- Total Equity
- 19.45
- Tangible Book Valueper Share Common Eq
- 28.17
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 2.69
- Cashfrom Investing Activities
- 0.29
- Cashfrom Financing Activities
- -0.04
- Net Changein Cash
- 2.95
- Period
- 2023-12-31
- Total Revenue
- 8
- Selling/ General/ Admin Expenses Total
- 0.71
- Depreciation/ Amortization
- 0.26
- Other Operating Expenses Total
- 0.72
- Total Operating Expense
- 6.5
- Operating Income
- 1.49
- Net Income Before Taxes
- 1.44
- Net Income
- 0.96
- Diluted Normalized EPS
- 1.5
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Source Natural Foods & Herb Supl Technical
Moving Average
SMA
- 5 Day167.21
- 10 Day165.47
- 20 Day164.8
- 50 Day166.65
- 100 Day167.8
- 300 Day192.38
Source Natural Foods & Herb Supl Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Samrat Pharmachem
- 399.9
- -0.95
- -0.24
- 646
- 302.05
- 123.51
- Parnax Lab
- 108.37
- 5.15
- 4.99
- 193.5
- 81
- 124.46
- Source Natural Foods & Herb Supl
- 178.9
- 2.35
- 1.33
- 269.75
- 80.2
- 113.01
- Mercury Laboratories
- 817.6
- -13.5
- -1.62
- 1190
- 736
- 98.11
- Godavari Drugs
- 99.57
- -12.25
- -10.96
- 155
- 79
- 74.98
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Samrat Pharmachem
- 57.27
- 1.91
- 22.06
- 4.03
- Parnax Lab
- 10.27
- 1.43
- 13.81
- 4.73
- Source Natural Foods & Herb Supl
- 64.38
- 5.84
- 16.06
- 10.56
- Mercury Laboratories
- 31.71
- 1.86
- 10.75
- 6.6
- Godavari Drugs
- 14.98
- 2.16
- 15.19
- 2.98
Source Natural Foods & Herb Supl Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 29-May-25
- Audited Results
- 13-Feb-25
- Quarterly Results
- 12-Nov-24
- Quarterly Results
- 14-Aug-24
- Quarterly Results
- 26-Jun-24
- Others
- 24-May-24
- Audited Results
- 14-Feb-24
- Quarterly Results
- 09-Nov-23
- Quarterly Results
- 11-Aug-23
- Quarterly Results
- 31-Jul-23
- Others
- Meeting Date
- Announced on
- Purpose
- 28-Jan-25
- 26-Dec-24
- POM
- 30-Sept-24
- 06-Sept-24
- AGM
- 06-Sept-23
- 14-Aug-23
- AGM
- 05-Aug-21
- 14-Jul-21
- AGM



